NCT00000539View on ClinicalTrials.gov

Arterial Disease Multifactorial Intervention Trial (ADMIT)

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 1992

Study Completion Date

March 31, 1999

Conditions
Arterial Occlusive DiseasesCardiovascular DiseasesHeart DiseasesVascular DiseasesDiabetes Mellitus
Interventions
DRUG

niacin

DRUG

pravastatin

DRUG

beta-carotene

DRUG

vitamin E

BEHAVIORAL

dietary supplements

DRUG

vitamin C

DRUG

warfarin

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00000539 - Arterial Disease Multifactorial Intervention Trial (ADMIT) | Biotech Hunter | Biotech Hunter